Lotus Bio-Technology Development Corp. (LBTD) Financial Statements

Lotus Bio-Technology Development Corp. (LBTD) files with the U.S. Securities and Exchange Commission under CIK 0001520592. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2016

Net Income: -$781.11 thousand
Total Assets: $5.46 thousand

Fiscal year ended Mar 31, 2016. Latest periodic SEC filing: Nov 21, 2016. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for LBTD in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History